Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.22.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flow from Operating Activities:    
Net loss available to common stockholders $ (4,040) $ (12,850)
Adjustments to reconcile net loss to net cash used in operating activities:    
Shares and warrants issued to third parties for services 0 46
Depreciation and amortization 409 411
Share-based compensation 1,091 2,544
Change in fair value of warrant liabilities 0 6,483
Payable-in-kind interest expense on notes payable 0 548
Other 237 69
Changes in operating assets and liabilities:    
Accounts receivable, net (2,925) (2,044)
Inventories, net (3,260) 287
Prepaid expenses and other assets 81 545
Accounts payable and accrued liabilities 728 1,735
Other 12 (99)
Cash Used in Operating Activities (7,667) (2,325)
Cash Flow from Investing Activities:    
Acquisition of property and equipment (150) 0
Cash Used in Investing Activities (150) 0
Cash Flow from Financing Activities:    
Proceeds from shares and warrants issued pursuant to private placement, net 0 4,012
Proceeds from revolving lines of credit 2,500 5,155
Payments on revolving lines of credit 0 (5,584)
Proceeds from term loan 0 6,000
Payments on term loans (200) (8,080)
Cash received for warrant exercises 0 1,310
Debt issuance costs (7) (116)
Cash Provided by Financing Activities 2,293 2,697
Net (decrease) increase in cash and cash equivalents and restricted cash (5,524) 372
Total cash and cash equivalents and restricted cash, beginning of period 28,942 3,989
Total cash and cash equivalents and restricted cash, end of period 23,418 4,361
Cash paid during the period for:    
Interest $ 67 $ 148